Zura Bio Limited

1.28
0.02 (1.19%)
At close: Mar 31, 2025, 3:59 PM
1.29
0.39%
After-hours: Mar 31, 2025, 04:36 PM EDT
1.19%
Bid 1.16
Market Cap 87.86M
Revenue (ttm) 1.82K
Net Income (ttm) -43.47M
EPS (ttm) -0.6
PE Ratio (ttm) -2.14
Forward PE -2.2
Analyst Buy
Ask 1.37
Volume 354,420
Avg. Volume (20D) 351,211
Open 1.28
Previous Close 1.26
Day's Range 1.17 - 1.35
52-Week Range 1.07 - 6.35
Beta 0.06

About ZURA

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California....

Industry Biotechnology
Sector Healthcare
IPO Date Mar 21, 2023
Employees 30
Stock Exchange NASDAQ
Ticker Symbol ZURA
Full Company Profile

Analyst Forecast

According to 7 analyst ratings, the average rating for ZURA stock is "Buy." The 12-month stock price forecast is $15, which is an increase of 1067.32% from the latest price.

Stock Forecasts
5 days ago
-10.07%
Zura Bio shares are trading lower after the compan... Unlock content with Pro Subscription
11 months ago
+17.89%
Zura Bio shares are trading higher. The company announced an oversubscribed $112.5 million private placement.